Archive: 25/09/2015
Tumor necrosis factor in colitis—bad actor or hero?
Investigators at Children's Hospital Los Angeles have found that a common therapeutic target for the treatment of inflammatory bowel disease (IBD) may actually protect against intestinal inflammation by inhibiting pathogenic ...
Sep 25, 2015
Scientists publish first complete record of genetic mutations behind rare vascular disease
The genetic architecture of a debilitating and potentially fatal vascular disease has for the first time been detailed in its entirety, providing clinicians with the comprehensive data needed to improve diagnosis and deliver ...
Sep 25, 2015